12:00 AM
 | 
Jul 31, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Protegrin IB-367 Rinse: Began Phase III trial

IntraBiotics Pharmaceuticals Inc. (IBPI), Mountain View, Calif.
Product: Protegrin IB-367 Rinse
Business: Infectious diseases
Therapeutic category: Bacterial infection
Target: Bacterial cell membranes...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >